Characteristics of cerebral ischemia in major rat stroke models of middle cerebral artery ligation through craniectomy

International Journal of Stroke

Volumn 9, Issue 6, 2014, Pages 793-801

  Shmonin, Alexey ^a,b   Melnikova, Elena ^b   Galagudza, Michael ^a,b   Vlasov, Timur ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Animal models; Area at risk; Collateral blood supply; Focal cerebral ischemia; Infarct size; Middle cerebral artery

Indexed keywords

TRIPHENYLTETRAZOLIUM; TETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BLOOD FLOW VELOCITY; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CRANIECTOMY; EXPERIMENTAL STROKE; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; STAINING; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; BRAIN; BRAIN CIRCULATION; CEREBRAL ARTERY DISEASE; CRANIOTOMY; DISEASE MODEL; HEMISPHERIC DOMINANCE; LIGATION; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; WISTAR RAT;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRAIN; BRAIN EDEMA; CEREBROVASCULAR CIRCULATION; CRANIOTOMY; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; INFARCTION, MIDDLE CEREBRAL ARTERY; LIGATION; MALE; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TETRAZOLIUM SALTS;

EID: 84904572852     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00947.x     Document Type: Article

References (31)

1. Roger VL, Go AS, Lloyd-Jones DM etal. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011; 123:e18-209.
2. Wang-Fischer Y, Prado R, Koetzner L. Anatomy and cerebral circulation of the rat; in Wang-Fischer Y (ed.): Manual of Stroke Models in Rats. New York, Taylor & Francis Group, 2009:13-25.
3. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986; 8:1-8.
4. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20:84-91.
5. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke 1998; 29:2162-2170.
6. Morikawa E, Ginsberg MD, Dietrich WD etal. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1992; 12:380-389.
7. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1:53-60.
8. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 1988; 8:474-485.
9. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 1986; 17:738-743.
10. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 1989; 256:H589-593.
11. Li Y, Kloner RA. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts. Circulation 1993; 87:1642-1648.
12. Kuschinsky W, Vogel J. Evolution of capillary perfusion deficits in ischemic rat brains; in Fukuuchi Y, Tomita M, Koto A (eds): Ischemic Blood Flow in the Brain. Tokyo, Springer-Verlag, 2001:241-248.
13. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion: statistical validation. Stroke 1995; 26:627-635.
14. Ikeda-Matsuo Y, Ota A, Fukada T, Uematsu S, Akira S, Sasaki Y. Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc Natl Acad Sci U S A 2006; 103:11790-11795.
15. Herz RC, Hillen B, Versteeg DH, De Wildt DJ. Collateral hemodynamics after middle cerebral artery occlusion in Wistar and Fischer-344 rats. Brain Res 1998; 793:289-296.
16. Angermaier A, Langner S, Kirsch M, Kessler C, Hosten N, Khaw AV. CT-angiographic collateralization predicts final infarct volume after intra-arterial thrombolysis for acute anterior circulation ischemic stroke. Cerebrovasc Dis 2011; 31:177-184.
17. Riva M, Pappada GB, Papadakis M etal. Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke. Exp Neurol 2012; 233:815-820.
18. Liszczak TM, Hedley-Whyte ET, Adams JF etal. Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol 1984; 65:150-157.
19. Coyle P. Middle cerebral artery occlusion in the young rat. Stroke 1982; 13:855-859.
20. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17:472-476.
21. Brozici M, van der Zwan A, Hillen B. Anatomy and functionality of leptomeningeal anastomoses: a review. Stroke 2003; 34:2750-2762.
22. Reza Noorian A, Nogueira R, Gupta R. Neuroprotection in acute ischemic stroke. J Neurosurg Sci 2011; 55:127-138.
23. Zukhurova M, Prosvirnina M, Daineko A etal. L-theanine administration results in neuroprotection and prevents glutamate receptor agonist-mediated injury in the rat model of cerebral ischemia-reperfusion. Phytother Res. 2012; DOI: 10.1002/ptr.4868.
24. Hanabusa K, Nagaya N, Iwase T etal. Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats. Stroke 2005; 36:853-858.
25. Esneault E, Castagne V, Moser P, Bonny C, Bernaudin M. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats. Neuroscience 2008; 152:308-320.
26. Cook DJ, Tymianski M. Translating promising preclinical neuroprotective therapies to human stroke trials. Expert Rev Cardiovasc Ther 2011; 9:433-449.
27. STAIR. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30:2752-2758.
28. Fisher M, Feuerstein G, Howells DW etal. STAIR Group. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40:2244-2250.
29. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1, 026 experimental treatments in acute stroke. Ann Neurol 2006; 59:467-477.
30. Yanamoto H, Nagata I, Niitsu Y, Xue JH, Zhang Z, Kikuchi H. Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique. Exp Neurol 2003; 182:261-274.
31. Reid E, Graham D, Lopez-Gonzalez MR, Holmes WM, Macrae IM, McCabe C. Penumbra detection using PWI/DWI mismatch MRI in a rat stroke model with and without comorbidity: comparison of methods. J Cereb Blood Flow Metab 2012; 32:1765-1777.